The pandemic has exposed longstanding vulnerabilities in the U.S. medical supply chain as well an overreliance on China and other countries, according to a new report on drug shortages by the majority staff on the Senate Committee on Homeland Security and Governmental Affairs.
Source: Drug Industry Daily